Adjusted Ebitda
Adaptive Biotechnologies·Business Segments·2 segments
Breakdown
Segments
Mrd BusinessView metric
Immune Medicine BusinessView metric
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Mrd Business | -$11.29M | -$6.12M | -$6.56M | -$4.11M | $1.91M | $6.97M | $10.42M | $12.14M |
| Immune Medicine Business | -$7.03M | -$5.21M | -$5.24M | -$5.11M | -$6.07M | $23.71M | — | -$10.36M |
| Total | -$11.29M | -$6.12M | -$6.56M | -$4.11M | $1.91M | $6.97M | $10.42M | $12.14M |